Carisma Therapeutics, Inc. (CARM)

Carisma Therapeutics Revenue

Carisma Therapeutics had revenue of $3.39M in the quarter ending September 30, 2024, a decrease of -11.55%. This brings the company's revenue in the last twelve months to $20.27M, up 41.13% year-over-year. In the year 2023, Carisma Therapeutics had annual revenue of $14.92M with 51.71% growth.

• Revenue (ttm): $20.27M
• Revenue Growth: +41.13%
• P/S Ratio: 1.67
• Revenue / Employee: $189,421
• Employees: 107
• Market Cap: 34.34M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	14.92M	5.09M	51.71%
Dec 31, 2022	9.83M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.